Editor’s note: This article was originally published as part of the Caleb’s Corner series and reflects perspectives on research commercialization from that period.
Research commercialization can feel like a completely different discipline from research itself. You may spend years developing a new technology, proving that it works, and building deep technical expertise, only to discover that taking it to market requires a very different mindset. Market demand, product design, pricing, sales, presentation, and licensing all become part of the equation.
If you are asking whether it is time to start selling, that usually means you have already crossed an important threshold. You believe the technology has value beyond your own lab. The harder question is whether it is ready to become a product, and whether you are ready to take on the work that comes with that decision.
Start with the market, not the invention
One of the first steps in research commercialization is understanding the market you plan to enter. In most cases, your potential customers already have some way of solving the problem. Your technology may be better, but that alone is not enough. You need to understand who the current players are, how established they are, and what gap still exists in the market.
A useful starting point is to study the companies already serving your space. Look at how large they are, how long they have been operating, whether they are still introducing new products, and how often their products appear in publications or other technical workflows. That helps you estimate whether you are entering a growing area, a mature one, or a crowded one.
You should also make a simple revenue estimate early. Multiply the number of realistic customers by the likely price point of your product. The result will not be perfect, but it can tell you whether the opportunity is worth pursuing. If the number is underwhelming even before accounting for costs, that is important to know.
Be realistic about the cost gap
A common mistake in academic startup commercialization is underestimating the distance between a working prototype and a sellable product. The version you built for your own use may be enough for the lab, but a commercial product usually needs to be easier to use, easier to support, safer, more durable, and better documented.
That is why product development costs tend to be underestimated so often. Time and budget almost always expand once you move from proof of concept to productization. Manufacturing, packaging, reliability, serviceability, regulatory needs, user training, and customer support all introduce new layers of work.
A practical mindset is to assume that the first estimate is optimistic. If you already think the transition will be difficult, it is probably more difficult than that.
Focus on the simplest product that solves the problem
One of the healthiest disciplines in taking research to market is simplification. The product does not need to express every idea that went into the invention. It needs to solve a real customer problem in the clearest possible way.
That means identifying the simplest embodiment of the technology that still achieves the intended function. Some features may have taken a great deal of time to develop, but if they are not essential to the first product, they may be better saved for later. A complicated product is harder to manufacture, harder to explain, harder to support, and often harder to sell.
Customers are usually not looking for complexity. They are looking for something that is easy to use, hard to break, and affordable to operate. Long learning curves, fragile components, and ongoing maintenance costs can become major barriers, even when the underlying technology is strong.
For a related perspective on product strategy, see our article on Build or Buy.
Presentation matters more than many technical founders expect
Many technical founders naturally focus on performance first. That makes sense, but research commercialization also depends heavily on presentation. The way the product looks, the clarity of the website, the quality of diagrams, and the overall professionalism of the brand all influence how seriously customers take the technology.
This does not mean style should outweigh function. It means perception matters. A product that looks unfinished may be judged as riskier, even if the underlying engineering is strong. Small improvements in industrial design, graphics, and web presentation can make a meaningful difference.
The same applies to sales and marketing. Good products rarely sell themselves. Even in specialized scientific markets, customers still need clear messaging, strong visuals, and repeated exposure before they are ready to buy. Many researchers underestimate this part of the process because it sits outside their normal training.
Decide whether you want to build a company or pursue licensing
Not every inventor needs to become a founder. One of the most important questions in commercializing university research is whether you actually want to build and operate a business. Starting a company can be rewarding, but it also shifts your time toward hiring, sales, operations, finances, and customer support.
Licensing is often a strong alternative. It allows the inventor to benefit from the commercial value of the technology while relying on a partner to manage manufacturing, sales, and go-to-market execution. In the right situation, that can be a better fit than building a company from scratch.
The key is to work with a licensing or commercialization partner that truly understands the technology and is committed to bringing it to market well. A weak partner can stall a promising invention just as easily as a weak startup plan.
When is it actually time to start selling?
There is no universal answer, but a few signs are usually helpful. It may be time to move forward when:
- the market need is clear
- the product can be simplified into a practical first version
- the commercial path is realistic
- the expected effort still feels worth it after a sober cost estimate
- you know whether you want to build, license, or partner
That is the point where research startup strategy becomes less theoretical and more actionable. You may still need iteration, but the decision is no longer only about invention. It becomes a decision about execution.
Final thoughts
Research commercialization is rarely a straight line. It asks researchers to think differently about value, risk, product design, cost, communication, and customer behaviour. That can be uncomfortable at first, but it is also what makes the transition from invention to impact possible.
If you are trying to decide whether it is time to start selling, the best place to start is with honesty. Is there a real market? Is the product simple enough? Are the costs manageable? Do you want to build a company, or would licensing make more sense? The clearer those answers become, the easier the next step will be.
For related reading, see Mechanical Testing of Biomaterials for Non-Engineers and Build or Buy.
